400
Participants
Start Date
September 28, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
March 31, 2027
Observational only: Serology and flow cytometry for ALL cohort participants
Blood samples from ALL cohort participants will be tested to measure antibodies to vaccine-preventable diseases and immune recovery
Observational only: Infection rates
Number of infections during the study period will be obtained from both ALL cohort and healthy control participants and captured for comparison and evaluation of infection rates during the first year off-chemotherapy.
Children's Hospital of Philadelphia, Philadelphia
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville
Helen DeVos Children's Hospital, Grand Rapids
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
CHRISTUS Children's (Affiliate of Baylor College of Medicine), San Antonio
Seattle Children's Hospital, Seattle
Merck Sharp & Dohme LLC
INDUSTRY
Children's Hospital of Philadelphia
OTHER